October 9, 2017 by Chain Drug Review
John Standley, Ken Martindale, Kermit Crawford, Rite Aid Walgreens, Walgreens Boots Alliance
2017, Issue 10-09-2017, Issues, News

CAMP HILL, Pa. — Rite Aid Corp. has landed a high-profile industry executive to help steer it through a transition phase into a much smaller company. Last week, former Walgreen Co. pharmacy chief Kermit Crawford joined Rite Aid as president and chief operating officer. Most recently at Walgreens, Crawford was a corporate executive vice president
October 9, 2017 by Geoff Walden and Chain Drug Review
CVS Pharmacy, CVS Times Square store, Discovery Zones, Judy Sansone, K-Beauty Shop-in-Shop, Trend Zone
2017, Issue 10-09-2017, Issues, News

WOONSOCKET, R.I. — CVS Pharmacy has debuted its largest store in New York City, a Times Square outlet that showcases the retailer’s new health and beauty focus. “We’re excited to bring our enhanced customer experience to Times Square, one of the world’s most vibrant and visited neighborhoods,” said Judy Sansone, senior vice president of front
October 9, 2017 by Geoff Walden and Chain Drug Review
Affordable Care Act, Bill Cassidy, Graham-Cassidy, John McCain, Lindsey Graham, Mitch McConnell, Obamacare, President Donald Trump, Rand Paul, Susan Collins
2017, Issue 10-09-2017, Issues, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — President Donald Trump said Obamacare would be repealed and replaced early next year, following the failure of the Senate’s latest effort to overturn the law. After the Senate pulled back from a vote on legislation that would have moved control of health insurance to the states, Trump said Republicans “have the votes” to
October 9, 2017 by Chain Drug Review
Brian Tanquilut, Jeffries, Rite Aid, Scott Mushkin, Walgreens Boots Alliance, Walgreens-Rite Aid merger, Wolfe Research
2017, Issue 10-09-2017, Issues, News
NEW YORK — Wall Street analysts say the fog around Walgreens Boots Alliance Inc. and Rite Aid Corp. is set to clear after a nearly two-year process that culminated in an unsuccessful merger and a deal to sell over 40% of Rite Aid’s stores to WBA. The Federal Trade Commission late last month approved a
October 9, 2017 by Chain Drug Review
Scott Wilks, Shoppers Drug Mart, Theresa Firestone, Wellwise by Shoppers Drug Mart
2017, Issue 10-09-2017, Issues, News

TORONTO — Shoppers Drug Mart (SDM) is reshaping the shopping experience for seniors with a new format here. The Wellwise by Shoppers Drug Mart outlet caters to the needs of aging Canadians who don’t want an “old person’s store,” says SDM senior vice president of health care businesses Theresa Firestone. Shopping for the elderly “doesn’t
October 9, 2017 by Geoff Walden and Chain Drug Review
Health Mart, Revene Remedies, Steve Courtman
2017, Issue 10-09-2017, Issues, News
IRVING, Texas — Health Mart has kicked off a Town Hall continuing education series titled “Revenue Remedies: Inject Profits into Your Business with Expanded Partnerships and Clinical Services.” The independent pharmacy network will host more than 80 events across the country through early next year. The new events will help pharmacies overcome barriers and maximize
October 9, 2017 by Bill Schiffner
IBM, IBM Cloud, Walgreens
2017, Issue 10-09-2017, Issues, News
DEERFIELD, Ill. — IBM has announced a new agreement with Walgreens to deploy IBM retail analytics at more than 8,100 locations nationwide to help improve the efficiency of field service support for these locations. With IBM’s support of IT systems at Walgreens stores, IBM’s unique capabilities to integrate hardware and software from different vendors under
October 9, 2017 by Bill Schiffner
CVS Caremark, CVS Health, CVS Health Foundation, CVS Pharmacy, Larry Merlo, Medication Disposal for Safer Communities Program, opioid abuse, opioid painkillers, opioid utilization management
2017, Issue 10-09-2017, Issues, News
WOONSOCKET, R.I. — CVS Health unveiled a major plan that utilizes all its integrated pharmacy assets to help combat misuse and abuse of opioid painkillers. The retailer said that its enterprisewide strategy to fight the opioid epidemic includes initiatives for safe drug disposal and utilization management of pain medications, as well as increased funding for
October 9, 2017 by Chain Drug Review
Alberta College of Pharmacists, College of Pharmacists of British Columbia, Greg Eberhart, Jedd Wood, pharmacy rewards, Sobeys, Sobeys National Pharmacy Group
2017, Issue 10-09-2017, Issues, News
EDMONTON, Alberta — An Alberta court has rebuffed Sobeys Inc.’s efforts to quash an Alberta College of Pharmacists (ACP) ban on loyalty rewards for prescription drug purchases. The Alberta Court of Appeal overturned a decision against the proposed ban last year. In that ruling, the court found no evidence of actual or potential harm to
October 9, 2017 by Todd Huseby and Chain Drug Review
A.T. Kearney, A.T. Kearney’s Global Business Policy Council, America@250, Todd Huseby
2017, Issue 10-09-2017, Issues, Opinion

On July 4, 2026, when America marks its 250th birthday, will the nation be stable and prosperous? That is the core question behind America@250 — a multiyear initiative launched by A.T. Kearney, in partnership with The Wall Street Journal. Muhtar Kent of Coca-Cola Co., Chip Bergh of Levi Strauss, Rhonda Vetere of Estée Lauder Cos.,
October 2, 2017 by Jeffrey Woldt and Chain Drug Review
John Standley Jeffrey Woldt, Ken Martindale, Kermit Crawford, Rite Aid, Walgreens, Walgreens Boots Alliance
Issue 10-09-2017, Leading Headlines, Opinion

September was an eventful month for Rite Aid Corp. In the wake of belated action by the Federal Trade Commission, the company moved quickly to dispel doubts about its future direction and begin the challenging task of operating more profitably from a smaller store base. Rite Aid had been under a cloud of uncertainty for
October 2, 2017 by Chain Drug Review
Brunet, Eric La Flèche, François Coutu, Jean Coutu, Jean Coutu Group, McMahon Distributeur Pharmaceutique, Metro, Metro-Jean Coutu Group merger
2017, Business, Featured Articles, Issue 10-09-2017, Issues, Leading Headlines, News, Retail News

MONTREAL — Just days after confirming talks about a potential deal, Metro Inc. and the Jean Coutu Group have agreed to merge. The companies said Monday that Metro plans to acquire Jean Coutu Group for $24.50 per share in cash and stock in a total deal valued at $4.5 billion ($3.6 billion U.S.). Under the